ClinicalTrials.gg
Status unknownNCT02934516PLUSUpdated Feb 28, 2020

Push With Lower Uterine Segment Support

An interventional study of Cesarean section in Dystocia, sponsored by Assiut University. Status unknown. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2020-02-28.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

The study aims to compare maternal and early neonatal outcomes of abdominal disimpaction with lower uterine segment support in comparison to the classic "push" method for delivery of impacted fetal head during Cesarean section for obstructed labor.

Read the detailed description

Obstructed labor refers to failure of labor progress in spite of good uterine contractions and is attributed to mismatch between the size of the presenting part of the fetus and the mother's pelvis. Approximately 8% of maternal deaths worldwide are attributed to obstructed labor and subsequent puerperal infection, uterine rupture, and postpartum hemorrhage.

In these situations, Cesarean section could minimize maternal and neonatal morbidity. However, Cesarean section is challenging when the head is deeply impacted and is associated with high risk of maternal injuries and perinatal injuries. The most common complication is extension of uterine incision which could involve the vagina, bladder, ureters and broad ligament. Neonates are also at risk of skull fractures, cephalhematoma, and subgaleal hematoma mainly due to manipulations. Currently, the most popular approaches for fetal head delivery are the push and pull methods. Although push method seems to be more convenient and does not necessitate extensive experience, it is more significantly associated with extension than the pull method. Although pull method seems to be more safe, it is more difficult to perform and usually warrants an aggressive uterine incision to deliver the fetus. In 2013, investigators published a case series on abdominal disimpaction with lower uterine segment support which basically allows obstetricians to deliver the fetal head through a transverse uterine incision with minimal risk of extensions and neonatal complications. In this study, investigators aim to validate this approach in comparison to the classic push method.

02

Conditions studied

  • Dystocia

Browse trials for

Keywords

  • Obstructed labor
  • C section. push method
  • reverse breech
03

In context

Dystocia

55 studies on the registry are indexed under Dystocia; 12 are open to participants now.

This study's planned enrollment of 66 is below the median of 200 across 42 interventional studies indexed under Dystocia.

Browse Dystocia studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Singleton term pregnancy, 37 to 42 weeks of gestation.
  • Cephalic presentation.
  • The cervix is fully dilated.
  • Ruptured membranes.
  • Adequate uterine contractions.
  • Impacted fetal head in maternal pelvis

Exclusion criteria

Exclusion Criteria:

  • Intrauterine fetal death
  • Major fetal anomalies
  • Non-cephalic presentation
  • Multiple pregnancy
  • Preterm caesarean \< 37 weeks
  • Abnormal placentation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Disimpaction with lower uterine support

    Cesarean section with support of the lower uterine segment

    Procedure: Cesarean section

  • Active comparator
    Classic push method

    Cesarean section with push method

    Procedure: Cesarean section

Interventions

  • ProcedureCesarean section

    Abdominal disimpaction with lower uterine segment support: the edge of the lower uterine segment is grasped by 3-4 modified Allies forceps (with broader jaws) applied along the lower edge of the incision until it is completely supported. These forceps are handled by the assistant, and gentle traction is applied upward, perpendicular to the uterine surface and away from the fetal head without excessive force. Accordingly, the hand of the surgeon could be inserted into the uterine cavity, and adequate space for manipulations is available without applying pressure on the lower segment. The fetal head is eventually grasped and delivered. Classic push method: delivering the head with assistance by pushing the fetal head vaginally

06

What researchers measure

Primary outcomes

  1. Extension of uterine incision

    The incidence of extension of uterine incision

    Time frame: During delivery of the fetus

  2. Length of extension of uterine incision

    If extension of uterine incision happens, the length of extension will be measured

    Time frame: During delivery of the fetus

  3. Injury of the vagina

    Extension of uterine incision into the vagina

    Time frame: During delivery of the fetus

  4. Injury of the bladder

    Extension of uterine incision into the bladder

    Time frame: During delivery of the fetus

  5. Injury of the ureter

    Extension of uterine incision into the ureter

    Time frame: During delivery of the fetus

Secondary outcomes

  1. Cesarean section operative time

    Duration of Cesarean section operation

    Time frame: Time from incision to closure of the skin (within 24 hours of recruitment)

  2. Intra-operative blood loss

    Amount of blood loss as estimated by suction device from incision to closure of the skin

    Time frame: During Cesarean section only

  3. The incidence of postpartum hemorrhage

    Loss of more than 500 ml during the first 24 hours after surgery and the management that will be done

    Time frame: During the first 24 hours post-operative

  4. Incidence of blood transfusion

    The incidence of blood transfusion due to significant blood loss (based on blood loss and clinical judgement "hypotension, tachycardia, pallor")

    Time frame: During surgery and within the first 24 hours postoperative

  5. Fetal traumatic birth injuries

    Skull fractures, limb fractures, brachial plexus injury, cephalhematoma, and subgaleal hematoma

    Time frame: During Cesarean section (fetal delivery)

  6. APGAR score

    Time frame: At 1 and 5 minutes after delivery of the newborn

  7. Need for neonatal admission to neonatal intensive care unit

    Time frame: Within 24 hours of delivery of the newborn

  8. Postoperative infections

    Puerperal sepsis and Cesarean section wound infection

    Time frame: 1 week of postpartum

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Dolea C, AbouZahr C. Global burden of obstructed labour in the year 2000. World Health Organization (WHO), Geneva, Switzerland. 2003 Jul;1:17.
  • Neilson JP, Lavender T, Quenby S, Wray S. Obstructed labour. Br Med Bull. 2003;67:191-204. doi: 10.1093/bmb/ldg018. PubMed 14711764 ↗
  • Landesman R, Graber EA. Abdominovaginal delivery: modification of the cesarean section operation to facilitate delivery of the impacted head. Am J Obstet Gynecol. 1984 Mar 15;148(6):707-10. doi: 10.1016/0002-9378(84)90551-9. PubMed 6702937 ↗
  • Shazly SA, Elsayed AH, Badran SM, Abdel Badee AY, Ali MK. Abdominal disimpaction with lower uterine segment support as a novel technique to minimize fetal and maternal morbidities during cesarean section for obstructed labor: a case series. Am J Perinatol. 2013 Sep;30(8):695-8. doi: 10.1055/s-0032-1331031. Epub 2012 Dec 27. PubMed 23271386 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2020; primary completion for Apr 2021, 11 months later.

Of 18 interventional studies with no phase under Dystocia, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 40. This study's planned 11 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2016
First posted
Oct 17, 2016
StartEst.
May 2020
Primary completionEst.
Apr 2021
CompletionEst.
Aug 2021
Last update
Feb 28, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 28, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02934516
Lead sponsor
Assiut University
Collaborators
Aswan University
Responsible party
Sherif Abdelkarim Mohammed Shazly (M.B.B.Ch, M.Sc, Assiut University) — Principal investigator
First posted
Oct 17, 2016
Start date
May 2020 (estimated)
Primary completion
Apr 2021 (estimated)
Completion
Aug 2021 (estimated)
Last update
Feb 28, 2020

Study contacts

Sherif A. Shazly, MBBCh, MSc
Contact
shazly.sherif2020@gmail.com
+15075131392
Amr Shehata, MBBCh, MD
Contact
Love_like902@Yahoo.com
Ahmed Nasr, MBBCh, MD
study director · Assiut University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion